An international group of multidisciplinary experts on middle-ear and paediatric infections
met to explore where consensus exists on the management of acute otitis media. After …

Background The burden of invasive pneumococcal disease in young children decreased
dramatically following introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) …

Abstract Objectives The Centers for Disease Control and Prevention considers carbapenem-
resistant Enterobacteriaceae (CRE) an urgent public health threat; however, its economic …

Abstract Background/Aims In April 2010 the 7-valent pneumococcal conjugate vaccine
(PCV7) was replaced by the 13-valent PCV. We investigated pneumococcal carriage in …

BACKGROUND. Since introduction of the heptavalent pneumococcal conjugate vaccine in
the United States in 2000, rates of invasive pneumococcal disease have declined. However …

This guide was developed to help meet the need of decision-makers for relevant, reliable
and consistent economic information; it aims to provide clear and concise, practical, high …

There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa
sub-optimally interrupt Streptococcus pneumoniae vaccine-serotype (VT) carriage and …

Background The sustained health-related quality-of-life of patients surviving community-
acquired pneumonia has not been accurately quantified. The aim of the current study was to …

The global burden of disease due to Streptococcus pneumoniae remains high. The licensed
7-valent pneumococcal conjugate vaccine (7vCRM, Prevenar™/Prevnar™) has successfully …

The number of economic evaluations related to infectious disease topics has increased over
the last 2 decades. However, many such evaluations rely on models that do not take into …